A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.

Multifunctional membrane-core nanoparticles, composed of calcium phosphate cores, arginine-rich peptides, cationic and PEGylated lipid membranes, and galactose targeting ligands, have been developed as synthetic vectors for efficient nuclear delivery of plasmid DNA and subsequent gene expression in hepatocytes in vivo. Targeted particles exhibited rapid and extensive hepatic accumulation and were predominantly internalized by hepatocytes, while the inclusion of such peptides in LCP was sufficient to elicit high degrees of nuclear translocation of plasmid DNA. Monocyclic CR8C significantly enhanced in vivo gene expression over 10-fold more than linear CR8C, likely due to a release-favoring mechanism of the DNA/peptide complex. Though 100-fold lower in activity than that achieved via hydrodynamic injection, this formulation presents as a much less invasive alternative. To our knowledge, this is the most effective synthetic vector for liver gene transfer.

[1]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[2]  K. L. Douglas Toward Development of Artificial Viruses for Gene Therapy: A Comparative Evaluation of Viral and Non‐viral Transfection , 2008, Biotechnology progress.

[3]  Yuma Yamada,et al.  Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. , 2008, Advanced drug delivery reviews.

[4]  Yang Liu,et al.  In vivo delivery of RNAi with lipid-based nanoparticles. , 2011, Annual review of biomedical engineering.

[5]  Leaf Huang,et al.  Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[7]  D. Perry Factor VII deficiency. , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  R. Pierce,et al.  Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo , 2009, Nucleic acids research.

[9]  A. Villaverde,et al.  Modular protein engineering for non-viral gene therapy. , 2004, Trends in biotechnology.

[10]  H Akita,et al.  Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery , 2007, Gene Therapy.

[11]  Yaping Li,et al.  Linear cationic click polymers/DNA nanoparticles: in vitro structure-activity relationship and in vivo evaluation for gene delivery. , 2011, Bioconjugate chemistry.

[12]  L. Chernomordik,et al.  Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery , 2005, Cellular and Molecular Life Sciences CMLS.

[13]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[14]  S. W. Kim,et al.  Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. , 2009, Biomaterials.

[15]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[16]  Biodistribution Studies of Nanoparticles Using Fluorescence Imaging: A Qualitative or Quantitative Method? , 2012, Pharmaceutical Research.

[17]  V. Puntes,et al.  Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting. , 2012, ACS nano.

[18]  Munia Ganguli,et al.  Differences in DNA condensation and release by lysine and arginine homopeptides govern their DNA delivery efficiencies. , 2011, Molecular pharmaceutics.

[19]  W. Saltzman,et al.  Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery. , 2011, Journal of biomedical materials research. Part A.

[20]  Minhyung Lee,et al.  Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  Kostas Kostarelos,et al.  Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. , 2011, Biomaterials.

[22]  J. Prakash,et al.  Drug targeting to the diseased liver. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[23]  E. Wisse,et al.  Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae , 2007, Gene Therapy.

[24]  Kam W. Leong,et al.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery , 2010, Journal of The Royal Society Interface.

[25]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[26]  D. Oupický,et al.  Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. , 2006, Bioconjugate chemistry.

[27]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[28]  H. Harashima,et al.  Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus , 2009, The AAPS Journal.

[29]  Wim E. Hennink,et al.  Artificial viruses: a nanotechnological approach to gene delivery , 2006, Nature Reviews Drug Discovery.

[30]  T. V. van Berkel,et al.  Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytesin Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[31]  A. Klibanov,et al.  Highly Effective Gene Transfection In Vivo by Alkylated Polyethylenimine , 2011, Journal of drug delivery.

[32]  K. Leong,et al.  Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[33]  S. Brüsselbach,et al.  Highly efficient transduction of endothelial cells by targeted artificial virus-like particles , 2001, Cancer Gene Therapy.

[34]  Yaping Li,et al.  Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. , 2008, International journal of pharmaceutics.

[35]  A. Villaverde,et al.  Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. , 2003, Human gene therapy.

[36]  Y. Maitani,et al.  Calcium enhanced delivery of tetraarginine-PEG-lipid-coated DNA/protamine complexes. , 2009, International journal of pharmaceutics.

[37]  I. Khalil,et al.  Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Wim E Hennink,et al.  Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells , 2001, Cancer Gene Therapy.

[39]  Sumati Sundaram,et al.  Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. , 2004, Annual review of biomedical engineering.

[40]  Darren H. Wakefield,et al.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes , 2007, Proceedings of the National Academy of Sciences.

[41]  Yu Chen,et al.  Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.

[42]  M. Schilsky Wilson disease: New insights into pathogenesis, diagnosis, and future therapy , 2005, Current gastroenterology reports.

[43]  S. Futaki,et al.  Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[44]  D. Stolz,et al.  Bifunctional compounds for targeted hepatic gene delivery , 2007, Gene Therapy.

[45]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[46]  T. Flotte,et al.  Gene therapy for alpha-1 antitrypsin deficiency. , 2011, Human molecular genetics.

[47]  Jason L. Townson,et al.  Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. , 2012, ACS nano.

[48]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[49]  E. Smiley,et al.  Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. , 2000, Bioconjugate chemistry.